Provided by Tiger Trade Technology Pte. Ltd.

Park Hotels & Resorts Inc.

11.53
+0.36003.22%
Post-market: 11.50-0.0300-0.26%17:34 EST
Volume:4.22M
Turnover:48.47M
Market Cap:2.30B
PE:-164.48
High:11.59
Open:11.24
Low:11.14
Close:11.17
52wk High:13.30
52wk Low:8.27
Shares:199.90M
Float Shares:195.63M
Volume Ratio:1.05
T/O Rate:2.16%
Dividend:1.00
Dividend Rate:8.67%
EPS(TTM):-0.0701
EPS(LYR):1.01
ROE:--
ROA:1.89%
PB:0.68
PE(LYR):11.42

Loading ...

Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288

GlobeNewswire
·
Yesterday

Did Park Hotels & Resorts' (PK) Portfolio Shift and Refinancing Just Reframe Its Investment Narrative?

Simply Wall St.
·
Yesterday

2025 Performance Forecasts Reveal Alcohol Producers' Resilience Under Pressure

Deep News
·
Feb 05

Park Hotels & Resorts Is Maintained at Hold by Truist Securities

Dow Jones
·
Feb 03

Truist Trims Price Target on Park Hotels & Resorts to $11 From $12, Keeps Hold Rating

MT Newswires Live
·
Feb 03

J.P. Morgan Sticks to Their Sell Rating for Park Hotels & Resorts (PK)

TIPRANKS
·
Feb 03

U.S. RESEARCH ROUNDUP-Adobe, Exxon Mobil, Stellar Bancorp

Reuters
·
Feb 03

What's Going On With Aquestive Therapeutics Stock After FDA Update For Lead Allergic Treatment?

Benzinga_recent_news
·
Feb 03

Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™

GlobeNewswire
·
Feb 02

Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth

GlobeNewswire
·
Feb 02

A Look At Park Hotels & Resorts (PK) Valuation After Mixed Recent Share Price Performance

Simply Wall St.
·
Jan 30

Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza

GlobeNewswire
·
Jan 26

BRIEF-Park Hotels & Resorts Inc. Announces Tax Treatment Of 2025 Dividends

Reuters
·
Jan 21

Park Hotels & Resorts Inc. Announces $1.00 Per Share 2025 Dividend Distribution

Reuters
·
Jan 21

Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson

GlobeNewswire
·
Jan 20

Weekly Scan of 40 New Funds: 26 Asset Managers Including Fullgoal, Penghua, ICBC Credit Suisse, ChinaAMC, and E Fund Compete with Thematic Index, FOF Stability, and Mixed Growth Offerings

Deep News
·
Jan 19

Director Christie B. Kelly Acquires Common Shares of Park Hotels & Resorts Inc

Reuters
·
Jan 17

Morgan Stanley Adjusts Price Target on Park Hotels & Resorts to $10 From $12, Maintains Equalweight Rating

MT Newswires Live
·
Jan 16

Shenzhen Company Ties Employee Weekend Schedules to Performance-Based Competition

Deep News
·
Jan 15

Park Hotels & Resorts (PK) Receives a Buy from Barclays

TIPRANKS
·
Jan 14